Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.

Contributions to nephrology

Volumn 66, Issue , 1988, Pages 85-93

  Bommer, J ^a   Kugel, M ^a   Schoeppe, W ^a   Brunkhorst, R ^a   Samtleben, W ^a   Bramsiepe, P ^a   Scigalla, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; RANDOMIZATION;

ADULT; ANEMIA; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; RANDOM ALLOCATION; RECOMBINANT PROTEINS;

EID: 0023758879     PISSN: 03025144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)